24 HR darifenacin 7.5 MG Extended Release Oral Tablet

Known as: darifenacin 7.5 MG 24HR Extended Release Oral Tablet, DARIFENACIN 7.5MG SA TAB, DARIFENACIN 7.5MG TAB,SA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2013
0120032013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
  • Prisma Pharmaforum
  • Uro-News
  • 2013
— Dass Blasenfunktionsstörungen wie Belastungsinkontinenz, überaktive Blase und Mischinkontinenz angesichts einer dramatischen… (More)
Is this relevant?
2009
2009
We have investigated the muscarinic receptor subtype(s) mediating the release of urinary bladder-derived relaxant factor that is… (More)
Is this relevant?
2008
2008
Das Leitthema dieses Heftes befasst sich mit dem täglichen Brot des Urologen in Klinik und Praxis, nämlich der medi­ kamentösen… (More)
Is this relevant?
2003
2003
Darifenacin [(S)-2--2,2-diphenylacetamide] is a novel antimuscarinic drug currently undergoing phase III trials for the treatment… (More)
Is this relevant?